Your browser doesn't support javascript.
loading
HERC5 is a prognostic biomarker for post-liver transplant recurrent human hepatocellular carcinoma.
Xue, Feng; Higgs, Brandon W; Huang, Jiaqi; Morehouse, Chris; Zhu, Wei; Yao, Xin; Brohawn, Philip; Xiao, Zhan; Sebastian, Yinong; Liu, Zheng; Xia, Yun; Shen, Dong; Kuziora, Mike; Dong, Zhengwei; Han, Hulin; Gu, Yi; Gu, Jianren; Xia, Qiang; Yao, Yihong.
Afiliação
  • Xue F; Department of Liver Surgery and Liver Transplantation, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 201203, China. fengxue6879@163.com.
  • Higgs BW; Translational Bioinformatics, MedImmune, Gaithersburg, MD, 20878, USA. higgsb@medimmune.com.
  • Huang J; Translational Bioinformatics, MedImmune, Gaithersburg, MD, 20878, USA. jiaqihuang94041@yahoo.com.
  • Morehouse C; Translational Bioinformatics, MedImmune, Gaithersburg, MD, 20878, USA. morehousec@medimmune.com.
  • Zhu W; Translational Bioinformatics, MedImmune, Gaithersburg, MD, 20878, USA. weizhu365@gmail.com.
  • Yao X; Translational Bioinformatics, MedImmune, Gaithersburg, MD, 20878, USA. yaox@medimmune.com.
  • Brohawn P; Translational Bioinformatics, MedImmune, Gaithersburg, MD, 20878, USA. brohawnp@medimmune.com.
  • Xiao Z; Translational Bioinformatics, MedImmune, Gaithersburg, MD, 20878, USA. xiaoz@medimmune.com.
  • Sebastian Y; Translational Bioinformatics, MedImmune, Gaithersburg, MD, 20878, USA. sebastiany@medimmune.com.
  • Liu Z; Translational Bioinformatics, MedImmune, Gaithersburg, MD, 20878, USA. zheng.r.liu@gmail.com.
  • Xia Y; Department of Liver Surgery and Liver Transplantation, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 201203, China. yunxia@163.com.
  • Shen D; Translational Bioinformatics, MedImmune, Gaithersburg, MD, 20878, USA. shend@medimmune.com.
  • Kuziora M; Translational Bioinformatics, MedImmune, Gaithersburg, MD, 20878, USA. kuzioram@medimmune.com.
  • Dong Z; Asia and Emerging Markets iMed, AstraZeneca R&D, 199 Liangjing Road, Shanghai, 201203, China. Harvey.Dong@astrazeneca.com.
  • Han H; Asia and Emerging Markets iMed, AstraZeneca R&D, 199 Liangjing Road, Shanghai, 201203, China. Hulin.Han@astrazeneca.com.
  • Gu Y; Asia and Emerging Markets iMed, AstraZeneca R&D, 199 Liangjing Road, Shanghai, 201203, China. Yi.Gu@astrazeneca.com.
  • Gu J; Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 201203, China. nlorg@public.sta.net.cn.
  • Xia Q; Department of Liver Surgery and Liver Transplantation, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 201203, China. xiaqiang@medmail.com.cn.
  • Yao Y; Translational Bioinformatics, MedImmune, Gaithersburg, MD, 20878, USA. oliver_67@yahoo.com.
J Transl Med ; 13: 379, 2015 Dec 11.
Article em En | MEDLINE | ID: mdl-26653219
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Transplante de Fígado / Carcinoma Hepatocelular / Peptídeos e Proteínas de Sinalização Intracelular / Neoplasias Hepáticas Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Transplante de Fígado / Carcinoma Hepatocelular / Peptídeos e Proteínas de Sinalização Intracelular / Neoplasias Hepáticas Idioma: En Ano de publicação: 2015 Tipo de documento: Article